Back to search

Article

Longitudinal visceral adipose heterogeneity supports digital health stratification of infliximab response loss in Crohn disease

2026-08-24

Abstract excerpt

<title>Abstract</title> <p>Secondary loss of response to infliximab is common in Crohn disease, but existing monitoring does not capture treatment-related changes in mesenteric adipose tissue. We developed a longitudinal computed tomography enterography-derived visceral adipose tissue heterogeneity score (VHS) and integrated its post-induction percentage change (%ΔVHS) with clinical disease behavior to stratify s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
eac6da13-dde7-53a4-8015-b68624cb0bae
DOI
10.21203/rs.3.rs-10658714/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Longitudinal visceral adipose heterogeneity supports digital health stratification of infliximab response loss in Crohn diseaseDOI 10.21203/rs.3.rs-10658714/v1
Select a neighboring publication to make it the new centre.